Skeletal muscle insulin resistance in morbid obesity: The role of interleukin-6 and leptin

Experimental and Clinical Endocrinology and Diabetes

Volumn 119, Issue 8, 2011, Pages 484-489

  Mitrou, P ^a   Lambadiari, V ^b   Maratou, E ^a   Boutati, E ^b   Komesidou, V ^c   Papakonstantinou, A ^c   Raptis, S A ^a,b   Dimitriadis, G ^b  

^a Prevention and Treatment of Diabetes Mellitus and Its Complications   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c EVANGELISMOS HOSPITAL   (Greece)

Author keywords

adipocytokines; leptin; obesity

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN; INTERLEUKIN 6; LEPTIN; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FOREARM BLOOD FLOW; GLUCOSE METABOLISM; HUMAN; INSULIN RESISTANCE; MORBID OBESITY; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RADIAL ARTERY; SKELETAL MUSCLE; SUBCUTANEOUS TISSUE;

ADIPONECTIN; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; FEMALE; FOREARM; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-6; KINETICS; LEPTIN; MUSCLE, SKELETAL; OBESITY, MORBID; POSTPRANDIAL PERIOD; REGIONAL BLOOD FLOW; RESISTIN; SUBCUTANEOUS FAT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80052664695     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0030-1269846     Document Type: Article

References (52)

1. Al-Khalili L, Bouzakri K, Glund S et al,. Signalling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle. Mol Endocrinol 2006 20 3364-3375 (Pubitemid 44833576)
2. Arita Y, Kihara S, Ouchi N et al,. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999 257 79-83 (Pubitemid 29299050)
3. Asano H, Izawa H, Nagata K et al,. Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population. Diabetologia 2010 53 234-246
4. Bastard J-P, Maachi M, Van Nhieu JT et al,. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 2002 87 2084-2089 (Pubitemid 34521492)
5. Beckers S, Peeters A, Freitas F et al,. Analysis of genetic variations in the resistin gene shows no associations in the resistin gene shows no associations with obesity in women. Obesity 2008 16 905-907 (Pubitemid 351465653)
6. Carey AL, Bruce CR, Sacchetti M et al,. Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness. Diabetologia 2004 47 1029-1037 (Pubitemid 38918162)
7. Carey AL, Steinberg GR, Macaulay SL et al,. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes 2006 55 2688-2697 (Pubitemid 44923666)
8. Caro J, Sinha M, Raju S et al,. Insulin receptor kinase in human skeletal muscle from obese subjects with and without non-insulin dependent diabetes. J Clin Invest 1987 79 1330-1337 (Pubitemid 17099635)
9. Chevrel G, Granet C, Miossec P. Contribution of tumour necrosis factor alpha and interleukin (IL) 1beta to IL-6 production, NF-kappa B nuclear translocation, and class 1 MHC expression in muscle cells: in vitro regulation with specific cytokine inhibitors. Ann Rheum Dis 2005 64 1257-1262 (Pubitemid 41206239)
10. Coppack S, Fisher R, Humphreys S et al,. Carbohydrate metabolism in insulin resistance: glucose uptake and lactate production by adipose tissue and forearm tissues in vivo before and after a mixed meal. Clin Sci 1996 90 409-415 (Pubitemid 26149409)
11. Cottam D, Mattar S, Barinas-Mitchell E et al,. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: Implications and effects of weight loss. Obes Surg 2004 14 589-600 (Pubitemid 38716577)
12. Curat C, Wegner V, Sengenes C et al,. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006 49 744-747 (Pubitemid 43357549)
13. Dimitriadis G, Boutati E, Lambadiari V et al,. Restoration of early insulin secretion after a meal in type 2 diabetes: effects on lipid and glucose metabolism. Eur J Clin Invest 2004 34 490-497 (Pubitemid 39049854)
14. Dimitriadis G, Newsholme E. Integration of some biochemical and physiologic effects of insulin that may play a role in the control of blood glucose concentration. In: LeRoith D, Taylor S, Olefsky J (eds) Diabetes Mellitus, a fundamental and clinical text Philadelphia, Baltimore, New York, London, Buenos Aires, Hong Kong, Sydney, Tokyo Lippincott Williams and Wilkins 2004 183-197
15. Dyck DJ, Heigenhauser GJF, Bruce CR. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiologica 2006 186 5-16
16. Dyck DJ. Adipokines as regulators of muscle metabolism and insulin sensitivity. Appl Physiol Nutr Metab 2009 34 396-402
17. Fain J, Madan A, Hiler M et al,. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix and adipocytes from visceral and subcutaneous abdominal adipose tissue of obese humans. Endocrinology 2004 145 2273-2282 (Pubitemid 38535056)
18. Fain J. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to nonfat cells. Vitam Horm 2006 74 443-477
19. Fantuzzi G. Adipose tissue, adipokines and inflammation. J Allergy Clin Immunol 2005 115 911-919
20. Fischer-Posovsky P, Wabitsch M, Hochberg Z. Endocrinology of adipose tissue an update. Horm Metab Res 2007 39 314-321
21. Franckhauser S, Elias I, Rotter Sopasakis V et al,. Overexpression of IL-6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice. Diabetologia 2008 51 1306-1316
22. Haseeb A, Iliyas M, Chakrabarti S et al,. Single-nucleotide polymorphisms in peroxisome proliferators activated receptor gamma and their association with plasma levels of resistin and the metabolic syndrome in a South Indian population. Journal of Biosciences 2009 34 405-414
23. Hivert MF, Sullivan L, Fox C et al,. Assiciations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. J Clin Endocrinol Metab 2008 93 3165-3172
24. Horowitz J, Coppack S, Klein S. Whole-body and adipose tissue glucose metabolism in response to short-term fasting in lean and obese women. Am J Clin Nutr 2001 73 517-522 (Pubitemid 32176501)
25. Hotta K, Funahashi T, Arita Y et al,. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arter Thromb Vasc Biol 2000 20 1595-1599 (Pubitemid 30353893)
26. Hu E, Liang P, Spiegelman BM. Adipo-q is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996 271 10697-10703 (Pubitemid 26145805)
27. Kern PA, Ranganathan S, Li C et al,. Adipose tissue tumour necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol 2001 280 E745-E751
28. Klein S, Coppack SW, Mohamed-Ali V et al,. Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes 1996 45 984-987 (Pubitemid 26225518)
29. Klover PJ, Zimmers TA, Koniaris LG et al,. Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 2003 52 2784-2789 (Pubitemid 37339708)
30. Kolterman O, Insel J, Saekow M et al,. Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects. J Clin Invest 1980 65 1272-1284 (Pubitemid 10122368)
31. Lee J, Chan J, Yiannakouris N et al,. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab 2003 88 4848-4856 (Pubitemid 37357535)
32. Maratos-Flyer E, Flyer JS. Obesity. In: Kahn CR, Weir GC, King GL, Jacobson AM, Moses AC, Smith RL (eds) Joslin's Diabetes Mellitus Philadelphia, Baltimore, New York, London, Buenos Aires, Hong Kong, Sydney, Tokyo Lippincott Williams and Wilkins 2005 533-546
33. Mitrou P, Boutati E, Lambadiari V et al,. Rates of glucose uptake in adipose tissue and muscle in vivo after a mixed meal in women with morbid obesity. J Clin Endocrinol Metab 2009 94 2958-2961
34. Mohamed-Ali V, Goodrick SJ, Rawesh A et al,. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-, in vivo. J Clin Endocrinol Metab 1997 8 4196-4200 (Pubitemid 27525539)
35. Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes 1982 2 1145-1158
36. Motoshima H, Wu X, Sinha M et al,. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab 2000 87 5662-5667 (Pubitemid 36034375)
37. Muller G, Ertl J, Gerl M et al,. Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J Biol Chem 1997 272 10585-10593 (Pubitemid 27181066)
38. Ofei F, Hurel S, Newkirk J et al,. Effects of an engineered human anti-TNF- antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 1996 45 881-885 (Pubitemid 26225502)
39. Paquot N, Castillo M, Lefebre P et al,. No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients. J Clin Endocrinol Metab 2000 85 1316-1319 (Pubitemid 32269392)
40. Pedersen BK. The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control. Essays Biochem 2006 42 105-117
41. Prager R, Wallace P, Olefsky J. Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects. Diabetes 1987 36 607-611 (Pubitemid 18024736)
42. Prager R, Wallace P, Olefsky J. In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects. J Clin Invest 1986 78 472-481 (Pubitemid 16074085)
43. Rabe K, Lehrke M, Parhofer KG et al,. Adipokines and insulin resistance. Mol Med 2008 14 741-751
44. Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumour necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 2003 278 45777-45784 (Pubitemid 37432722)
45. Sabin M, Holly J, Shield J et al,. Mature subcutaneous and visceral adipocytes concentrations of adiponectin are highly correlated in prepubertal children and inversely related to body mass index standard deviation score. J Clin Endocrinol Metab 2006 91 332-335 (Pubitemid 43069158)
46. Savage D, Sewter C, Klenk E et al,. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 2001 50 2199-2202 (Pubitemid 33641901)
47. Senn JJ, Klover PJ, Nowak IA et al,. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 2002 51 3391-3399 (Pubitemid 35403441)
48. Shetty G, Economides P, Horton E et al,. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes care 2004 27 2450-2457 (Pubitemid 39281400)
49. Shimomura I, Hammer RE, Ikemoto S et al,. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 1999 401 73-76
50. Statnick MA, Beavers LS, Conner LJ et al,. Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Exp Diabetes Res 2000 1 81-88
51. Weyer C, Funahashi T, Tanaka S et al,. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001 86 1930-1935 (Pubitemid 32472900)
52. Yaspelkis BB, Davis JR, Saberi M et al,. Leptin administration improves skeletal muscle insulin responsiveness in diet-induced insulin resistant rats. Am J Physiol 2001 280 E130-E142